Search

Your search keyword '"Agostoni P"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Agostoni P" Remove constraint Author: "Agostoni P" Topic medicine Remove constraint Topic: medicine
133 results on '"Agostoni P"'

Search Results

1. Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID

2. Non-surgical management of methicillin-sensitive Staphylococcus aureus bacteremia-related mediastinitis

3. Two is better than one: the double diffusion technique in classifying heart failure

4. Mother-to-child transmission of SARS-CoV-2 infection in high-income countries: a systematic review and meta-analysis of prospective observational studies

5. Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature

6. Digital PCR for high sensitivity viral detection in false-negative SARS-CoV-2 patients

7. Seasonal variability of the vitamin D effect on physical fitness in adolescents

8. Validation of a new wearable device for type 3 sleep test without flowmeter.

9. Risk of adverse events in gastrointestinal endoscopy: Zero-inflated Poisson regression mixture model for count data and multinomial logit model for the type of event.

10. Pretreatment maternal lifestyle and outcomes of assisted reproduction: an Italian cohort study

11. COVID-19 Vaccine Hesitancy among Parents of Children and Adolescents Living in Brazil

12. Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells

13. Hyponatremia in infants with community-acquired infections on hospital admission.

14. Exercise gas exchange in continuous-flow left ventricular assist device recipients.

15. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

16. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

17. Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction

18. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

19. Are Treated Celiac Patients at Risk for Mycotoxins? An Italian Case-Study

20. Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans.

21. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

22. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

23. Effects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamics.

24. Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

25. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

26. Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure

27. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

28. Prognostic value of indeterminable anaerobic threshold in heart failure

29. Panethnic differences in blood pressure in Europe: A systematic review and meta-analysis

30. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

31. High-altitude hypoxia and periodic breathing during sleep: gender-related differences

32. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure

33. EURObservational Research Programme:regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)

34. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

35. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study

36. Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation

37. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid‐range ejection fraction

38. Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation

39. Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

40. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias

41. The prognostic value of serial troponin measurements in patients admitted for COVID-19

42. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering

43. Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study

44. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study

45. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

46. RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

47. Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study

48. Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test

49. The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study

50. Qualitative and quantitative evaluation of a new wearable device for ECG and respiratory Holter monitoring

Catalog

Books, media, physical & digital resources